Researchers seeking to buy TB-500 (Thymosin Beta-4) will find it among the most extensively studied tissue repair peptides in preclinical literature. TB-500 is a synthetic analogue of the naturally occurring Thymosin Beta-4 protein, a 43-amino-acid peptide that plays a central role in actin sequestration, cell migration, and angiogenesis. EdgeChems supplies TB-500 for sale as a research-grade compound at ≥98% purity, HPLC-verified with third-party COA documentation.
What Is TB-500 (Thymosin Beta-4)?
Thymosin Beta-4 (TB4) is an endogenous peptide first isolated from the bovine thymus in the 1970s. It is encoded in most eukaryotic cells and is one of the most abundant intracellular peptides in mammalian tissue — present at particularly high concentrations in blood platelets and wound-healing tissue. The synthetic research analogue TB-500 replicates the active region of Thymosin Beta-4 responsible for actin binding and cellular migration effects observed in controlled studies.
The peptide’s primary structural feature is its actin-binding domain: a LKKTET (Leu-Lys-Lys-Thr-Glu-Thr) hexapeptide motif that sequesters G-actin (globular actin) and regulates the G-actin to F-actin (filamentous actin) balance inside cells. This actin dynamic regulation is central to cell motility, tissue remodelling, and wound closure mechanisms studied in preclinical models.
Mechanisms of Action
- Actin sequestration: TB-500 binds G-actin monomers via its LKKTET domain, modulating the intracellular actin pool and influencing cytoskeletal dynamics critical for cell migration.
- Angiogenesis promotion: Multiple in vitro and animal model studies demonstrate TB-500 upregulates VEGF receptor expression and promotes endothelial cell tube formation — a key step in new blood vessel formation for tissue repair research.
- Anti-inflammatory signalling: Research in inflammatory models shows TB-500 downregulates pro-inflammatory cytokines including NF-kB-pathway mediators, relevant to wound healing and tissue recovery models.
- Stem cell migration: Studies in cardiac and neural injury models show Thymosin Beta-4 promotes stem cell homing to injury sites — an area of active preclinical investigation.
- Hair follicle activation: In vitro studies on hair follicle stem cells show TB-500 activates progenitor cells, studied in alopecia research models.
TB-500 in Musculoskeletal Research
The most replicated preclinical findings for TB-500 involve musculoskeletal tissue repair models. In rodent studies of tendon injury, ligament transection, and muscle laceration, TB-500 administration is associated with accelerated histological repair markers including collagen fiber organization, fibroblast proliferation, and revascularisation at injury sites.
TB-500 is frequently studied in combination with BPC-157 for complementary tissue repair mechanisms — TB-500 targeting actin polymerization and angiogenesis while BPC-157 addresses NO-pathway and fibroblast signalling. EdgeChems offers a pre-formulated BPC-157 + TB-500 Blend for researchers studying both pathways simultaneously. This combination is one of the most popular dual-peptide research preparations in the preclinical tissue repair literature.
TB-500 in Cardiac Research
Beyond musculoskeletal tissue, TB-500 has drawn significant research interest in cardiac injury models. Studies in rodent myocardial infarction models show Thymosin Beta-4 administration is associated with cardiomyocyte survival signalling, reduced apoptosis markers, and enhanced revascularisation. Published work in journals including Nature and Circulation has examined TB4 in the context of cardiac progenitor cell activation — though all findings remain preclinical and no human therapeutic use has been approved.
Product Specifications — Buy TB-500 From EdgeChems
- Compound: TB-500 (Thymosin Beta-4 synthetic analogue)
- Format: Lyophilized powder or liquid (see product page)
- Purity: ≥98% (third-party HPLC verified)
- Molecular Weight: ~4963 Da
- Storage: -20°C, protected from light and moisture
- Stability: 24 months sealed
Order TB-500 for sale from EdgeChems with full HPLC documentation and discreet packaging. Every vial ships with third-party COA verification.
Research Applications Summary
- Musculoskeletal tissue repair models (tendon, ligament, muscle)
- Angiogenesis and wound healing studies
- Cardiac injury and cardioprotection research
- Anti-inflammatory cytokine modulation studies
- Hair follicle and stem cell activation research
- Actin polymerization and cytoskeletal dynamics investigations
TB-500 vs Thymosin Alpha-1
Researchers sometimes conflate TB-500 (Thymosin Beta-4 analogue) with Thymosin Alpha-1 — a distinct peptide from the same thymosin protein family. Thymosin Alpha-1 is primarily studied for immune modulation, particularly T-cell activation and antiviral signalling, whereas TB-500/Thymosin Beta-4 is studied for tissue repair, actin dynamics, and angiogenesis. The two peptides have different sequences, mechanisms, and research applications and should not be treated as interchangeable.
For research purposes only. Not intended for human or veterinary use. All information is presented for scientific reference.